newsfilter
← Latest News
GlobeNewswire·

Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs

SEATTLE and CAMBRIDGE, United Kingdom, April 05, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ:ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in